Research

This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.

“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” researchers say.

Compass Pathways (Nasdaq: CMPS) has announced the launch of a brand new psychedelic clinical trial, using psilocybin (the active ingredient in magic mushrooms) to treat PTSD, and there are multiple reasons to be excited about it. The Phase-2…

"This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding," says Cybin's chief clinical officer.

There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer "unprecedented" potential.

"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.

Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.

“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments," explains University of Queensland mycologist Dr. Alistair McTaggart.

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.

The trial will build on Diamond Therapeutic's previous animal research that demonstrated how non-hallucinogenic doses of psilocybin hold the potential to treat psychiatric disorders, including anxiety and depression.

Take a deep dive into the history, effects, and benefits of this psychoactive plant that is still largely under the radar as interest in psychedelics explodes.

DMT treating eye disease? Psilocybin reducing obesity? The benefits of psychedelics could be truly far out as research continues to find novel applications.

Psychae Institute will collaborate with other clinical research organizations to develop novel psychedelic medicines and accompanying psychotherapeutic treatment models.

New study compiles the experiences of 8,629 ayahuasca users from 40 different countries, and results are very promising for the future of psychedelic-assisted therapy.

And why the two-time Stanley Cup champion does not imagine working with the NHL in the "near future."

The deal creates Wesana Clinics, a chain of mental health facilities focused on delivering psychedelic-assisted psychiatric care, as well as data platform Wesana Solutions.

Here's how to become a research subject for psilocybin, LSD, MDMA, ibogaine, and 5-MeO-DMT studies.

Alcohol, methamphetamine and cocaine have been linked to increased aggression in men, but psychedelics appear to have opposite effect.

Significant personal experiences on the psychedelic mescaline show great promise in treating anxiety and depression, new research finds.

Psychedelic life sciences company Wesana Health has partnered with the University of South Carolina to study brain health.

The University of Alabama at Birmingham is the latest to announce it will begin research into psychedelics.

Psychedelic biotech company PharmaTher says its ketamine patch could help relieve depression better than other treatments.

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.

A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.

In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.

Psychedelic life sciences company MindMed is exploring LSD as a means of pain management.

A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.

A potent tool in the battle against opioid addiction, ibogaine treatment is the subject of a new study in the UK.

Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.

Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.

Psychedelic research is coming to the University of California in a new division to study MDMA.

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.

Psychedelic use may help to decrease the risk of hypertension, according to new research.

The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.

Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.

A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.

NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.

Clinical trials will look at the benefits of 5-MEO DMT as a treatment for relief from a number of mental health issues including depression.

The UK will begin the first DMT trials for depression after Imperial College received approval to test the psychedelic.

A new study links microdosing psychedelics to improved mental health in the vast majority of subjects. Microdosing involves taking small amounts of substances such as LSD or psilocybin over an extended period of time. The low-level dosages…

Psychedelic-like states of consciousness may soon be achievable without the need for substances like ketamine, psilocybin, or MDMA. A new study, published in the journal Nature, suggests the ability to replicate these altered states of consciousness…

Rafael was apprehensive at first. Sitting on a yoga mat facing the setting sun, he whispered to his wife, “I’m scared.” R5-MeO-DMT was a religious experience for Rafael. Recounting his second journey on the outlawed chemical on 5Hive,…

https://www.youtube.com/watch?v=oJiDDATv9uU&feature=emb_logo

The traditional Amazonian psychedelic concoction, Ayahuasca, has begun to receive widespread attention for its powerfully therapeutic benefits. As countless people from across the globe travel to destinations like Mexico and South America to…